title: Toxic epidermal necrolysis after mifepristone/gemeprost-induced abortion.
authors.affiliation: Dermatology Clinic, Hôpital Charles Nicolle, Rouen, France.
authors.forename: C
authors.initials: C
authors.lastname: Lecorvaisier-Pieto
authors.forename: P
authors.initials: P
authors.lastname: Joly
authors.forename: E
authors.initials: E
authors.lastname: Thomine
authors.forename: S
authors.initials: S
authors.lastname: Tanasescu
authors.forename: C
authors.initials: C
authors.lastname: Noblet
authors.forename: P
authors.initials: P
authors.lastname: Lauret
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects*; D000021:Abortifacient Agents, Steroidal / Q000009:adverse effects*; D000028:Abortion, Induced; D000328:Adult; D000527:Alprostadil / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D006727:Hormone Antagonists / Q000009:adverse effects; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects*; D011247:Pregnancy; D011459:Prostaglandins E, Synthetic / Q000009:adverse effects; D013262:Stevens-Johnson Syndrome / Q000209:etiology*
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D006727:Hormone Antagonists; D011459:Prostaglandins E, Synthetic; D015735:Mifepristone; C021182:gemeprost; D000527:Alprostadil